AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22422274
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care with toothbrushing and 0.12% chlorhexidine digluconate
Trial: 22422274
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care without toothbrushing and 0.12% chlorhexidine digluconate
Trial: 18635695
Drug: bupropion XR
RxNorm normalized name: bupropion Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion XR (150 mg/day, increased to 300 mg/day if inadequate response)
Trial: 18635695
Drug: venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: venlafaxine XR (75 mg/day, increased to 150 mg/day if inadequate response)
Trial: 17617284
Drug: Topical epinastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical epinastine hydrochloride ophthalmic solution 0.05% twice daily for 4 days
Trial: 17617284
Drug: Systemic loratadine
RxNorm normalized name: Loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic loratadine 10 mg once daily for 4 days
Trial: 26611782
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole 500 mg twice daily for 7 days
Trial: 17061489
Drug: Oral ampicillin
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ampicillin 2 g for 10 days
Trial: 8081076
Drug: Telenzepine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telenzepine 1.5 mg nocte
Trial: 8081076
Drug: Telenzepine 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telenzepine 3 mg nocte
Trial: 8081076
Drug: Telenzepine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telenzepine 5 mg nocte
Trial: 18398627
Drug: Full dental
RxNorm normalized name: Full Marks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dental treatment
Trial: 20111879
Drug: No invasive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No invasive treatment
Trial: 20111879
Drug: Other treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatment strategies
Trial: 12174003
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine administered into the ventrogluteal area
Trial: 12174003
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine administered into the anterolateral thigh
Trial: 8005300
Drug: RU486 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU486 (1 mg/d for 5 days)
Trial: 31899117
Drug: Ultrasonography-guided corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasonography-guided corticosteroid injection (CI)
Trial: 31899117
Drug: Blind corticosteroid
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind corticosteroid injection (CI)
Trial: 28368486
Drug: Pulsatile GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsatile GnRH therapy administered subcutaneously for 3 months
Trial: 23298894
Drug: Pulsatile GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsatile GnRH therapy
Trial: 26637582
Drug: Topical Vitamin
RxNorm normalized name: vitamin A Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Vitamin A (VA)
Trial: 24026893
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 1000 mg daily + cholecalciferol 1600 IU daily
Trial: 24026893
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 1000 mg daily
Trial: 21566104
Drug: Rituximab (Mabthera,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (Mabthera, 375 mg/m² intravenously) with lower doses of prednisone and calcineurin inhibitors
Trial: 21566104
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (current therapy alone)
Trial: 16040117
Drug: Position of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Position of the preparation margin
Trial: 12548298
Drug: TCP dispersed
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCP dispersed in water containing 1200 mg Ca
Trial: 12548298
Drug: HCSM containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCSM containing 1200 mg Ca and 65.5 mg Mg
Trial: 12548298
Drug: HCSM containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCSM containing 1200 mg Ca and 172 mg Mg
Trial: 12548298
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium drinks (TCP, HCSM, HCSM+Mg)
Trial: 9297766
Drug: Strontium-89 systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strontium-89 systemic radiotherapy (single injection)
Trial: 3899046
Drug: Methylphenidate hydrochloride
RxNorm normalized name: Methylphenidate Hydrochloride
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate hydrochloride (0.15 mg/kg)
Trial: 7771914
Drug: Methylphenidate hydrochloride
RxNorm normalized name: Methylphenidate Hydrochloride
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate hydrochloride (0.3 mg/kg)
Trial: 3899046
Drug: Methylphenidate hydrochloride
RxNorm normalized name: Methylphenidate Hydrochloride
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate hydrochloride (0.6 mg/kg)
Trial: 30224584
Drug: Brief Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief Cognitive Behavioral Therapy for Insomnia (CBT-I) consisting of a group session (60 min) and an individual session (30 min)
Trial: 26654214
Drug: 11-G vacuum-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-G vacuum-assisted biopsy (VAB)
Trial: 26654214
Drug: 14-G core
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 14-G core needle biopsy (CNB)
Trial: 22898577
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy training alone (PT group)
Trial: 22898577
Drug: Both physical
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both physical therapy and Wii Fit training (PW group)
Trial: 22898577
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy training (PT group)
Trial: 17852170
Drug: Individual cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive behavioral therapy with attention to relapse prevention
Trial: 7743301
Drug: Lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (30 mg every morning for 3 weeks)
Trial: 2040103
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of prednisone for 14 days
Trial: 6165428
Drug: Preparation purified
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation purified by passage twice through a monoclonal antibody affinity chromatography column (NK21F)
Trial: 25995489
Drug: Multimodal pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal pain regimen with periarticular injection (PAI)
Trial: 24338139
Drug: Milrinone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milrinone (50 μg/kg intravenously followed by 24 hours infusion at 0.5 μg/kg/min)
Trial: 17664328
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) and Lamivudine (3TC) administered once daily (QD)
Trial: 17664328
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) and Lamivudine (3TC) administered twice daily (BID)
Trial: 2677227
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified pork insulin (Nordisk, Denmark)
Trial: 2677227
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin of recombinant DNA origin (Eli Lilly, USA)
Trial: 27809613
Drug: Minimal enteral
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal enteral feed (MEF) supplemented with intravenous fluid (IVF), n=52
Trial: 24195786
Drug: Imidapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril (10 - 20 mg once daily)
Trial: 24195786
Drug: Ramipril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (5 - 10 mg once daily)
Trial: 19957508
Drug: Combined intercostal
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined intercostal nerves block-sevoflurane used inhalation anesthesia with laryngeal mask ventilation
Trial: 19957508
Drug: Sevoflurane used
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane used inhalation anesthesia with laryngeal mask ventilation (Control Group)
Trial: 15549276
Drug: Cocoa powder
RxNorm normalized name: Cocoa powder
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa powder (11.6 g)
Trial: 15549276
Drug: Caffeine (19
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (19 mg) and theobromine (250 mg) combination
Trial: 15549276
Drug: Milk chocolate
RxNorm normalized name: Meritene Milk Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk chocolate (methylxanthine doses)
Trial: 15549276
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (methylxanthine doses)
Trial: 11510029
Drug: Gemcitabine (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1,200 mg/m² IV on days 1 and 8) plus Carboplatin (AUC 5 IV on day 1)
Trial: 11510029
Drug: Cisplatin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (60 mg/m² IV on day 1) plus Etoposide (120 mg/m² IV on day 1 and 100 mg orally on days 2 and 3)
Trial: 11066188
Drug: Empirical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical treatment approaches
Trial: 11066188
Drug: Genetic predisposition
RxNorm normalized name: Burosumab (genetical recombination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetic predisposition awareness and manipulation of biological pathways
Trial: 9001663
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg/day i.v.)
Trial: 6394004
Drug: Cefaclor, 250
RxNorm normalized name: Cefaclor, 250 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor, 250 mg twice daily for 10 days
Trial: 6394004
Drug: Ampicillin, 500
RxNorm normalized name: Ampicillin, 500 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin, 500 mg four times daily for 10 days
Trial: 22392168
Drug: Sucrose administered
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose administered before heel lance
Trial: 20435991
Drug: small-molecule glycoprotein
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: small-molecule glycoprotein IIb/IIIa inhibitors (smGPIs)
Trial: 18687841
Drug: Iodine-based solution
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine-based solution preparation for 90 seconds
Trial: 18687841
Drug: Clear fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clear fluid antiseptic preparation for 60 seconds
Trial: 18687841
Drug: Clear fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clear fluid antiseptic preparation for 90 seconds
Trial: 18687841
Drug: Iodine-based solution
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine-based solution preparation for 60 seconds
Trial: 30454876
Drug: Agent support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agent support
Trial: 29869004
Drug: Intramuscular supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular supplementation of vitamin D with a single dose of 600,000 IU cholecalciferol
Trial: 29869004
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral supplementation limited to 1400 IU of vitamin D)
Trial: 27160498
Drug: Integrated nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated nutritional therapy (oral, enteral, and parenteral)
Trial: 10953902
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g/day for 5 days to 3 g/day for 9 weeks)
Trial: 9105072
Drug: Surfactant (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant (up to four doses of 100 mg phospholipids/kg)
Trial: 1337163
Drug: Low calcium
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calcium PD fluid (calcium 1.25 mmol/l) with oral calcium carbonate
Trial: 1337163
Drug: Standard PD
RxNorm normalized name: PD-0299685
DrugBank: PD-0299685 (DB15264)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard PD solution (calcium 1.75 mmol/l) with calcium carbonate plus aluminium hydroxide phosphate binders
Trial: 1337163
Drug: Low calcium
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calcium PD fluid (calcium 1.25 mmol/l)
Trial: 1337163
Drug: Standard PD
RxNorm normalized name: PD-0299685
DrugBank: PD-0299685 (DB15264)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard PD solution (calcium 1.75 mmol/l)
Trial: 2435043
Drug: Oral phenoxybenzamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral phenoxybenzamine (10 mg b.i.d.; n = 21)
Trial: 2435043
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets (n = 22)
Trial: 29634086
Drug: Multilevel cardiovascular
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multilevel cardiovascular disease prevention program (6 months, twice-weekly exercise, nutrition, and heart health classes)
Trial: 27792801
Drug: Methacrylate-based composite
RxNorm normalized name: methacrylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacrylate-based composite resin (Filtek Z250) with oxalic acid-based desensitizing agent (Desenssiv, SSWhite)
Trial: 27792801
Drug: Silorane-based composite
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silorane-based composite resin (Silorane P90) with oxalic acid-based desensitizing agent (Desenssiv, SSWhite)
Trial: 15696400
Drug: Sotalol (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (1.5 mg/kg)
Trial: 6617715
Drug: Flecainide (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (2 mg/kg)
Trial: 12889588
Drug: Metronidazole treatment
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole treatment for trichomoniasis
Trial: 12889588
Drug: Metronidazole treatment
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole treatment for bacterial vaginosis
Trial: 31512143
Drug: TurboCBD™ 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TurboCBD™ 90 mg
Trial: 31512143
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg control
Trial: 21899812
Drug: Salicylic acid
RxNorm normalized name: Salicylic Acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salicylic acid (50% self-treatment)
Trial: 19473560
Drug: Intraarticular injection
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular injection with triamcinolone hexacetonide 60 mg and xylocaine chloride 2% (IAI group)
Trial: 19473560
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of triamcinolone acetonide 60 mg and xylocaine chloride 2% (IM group)
Trial: 12374678
Drug: Oral alpha-difluoromethylornithine
RxNorm normalized name: alpha-difluoromethylornithine
DrugBank: Eflornithine (DB06243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alpha-difluoromethylornithine (DFMO) 0.5 g/m(2)/day for 6 months
Trial: 2154068
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin infusions (500 mg/kg x 3 doses, followed by 250 mg/kg x 2 doses at 2-week intervals)
Trial: 7276205
Drug: Distalgesic (paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distalgesic (paracetamol and dextropropoxyphene)
Trial: 28884989
Drug: Hydroxychloroquine (HCQ)
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (HCQ) 400 mg daily for 12 weeks
Trial: 19700936
Drug: Leukotriene receptor
RxNorm normalized name: Leukotriene receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene receptor antagonist (LTRA)
Trial: 25872950
Drug: Five weekly
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five weekly psychosocial interventions based on cognitive behavioral therapy (CBT) in combination with early palliative care (PC)
Trial: 19763132
Drug: losartan/hydrochlorothiazide (L/HCTZ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan/hydrochlorothiazide (L/HCTZ)
Trial: 17088140
Drug: Reslizumab at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reslizumab at 3 mg/kg
Trial: 17088140
Drug: Reslizumab at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reslizumab at 1 mg/kg
Trial: 7967420
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with 2 therapy courses for completely resected patients (branch R1)
Trial: 7967420
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with 4 therapy courses for patients with extra-abdominal localization or abdominal localization and LDH < 500 U/l (branch R2)
Trial: 7967420
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with 6 therapy courses for patients with abdominal localization and LDH >= 500 U/l (branch R3)
Trial: 7967420
Drug: Intensification therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensification therapy for patients with incomplete response after 2 courses
Trial: 7967420
Drug: CNS chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CNS chemotherapy for CNS positive patients
Trial: 7967420
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of pEFS for stage III abdominal disease and LDH >= 500 U/l
Trial: 2889307
Drug: Idazoxan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idazoxan (20 mg po, three times a day)
Trial: 23116214
Drug: Unani formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unani formulation for ulcer healing
Trial: 12358335
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone (BDP) at doses of 50, 100, 200, or 500 microg x day(‐1) for eight weeks
Trial: 10076146
Drug: Carbetocin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbetocin (100 microg single dose)
Trial: 10076146
Drug: Oxytocin (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (standard 8-hour infusion)
Trial: 7572651
Drug: Enalapril (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (1 mg intravenous, followed by oral therapy)
Trial: 2404556
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) and heparin; 1 g 5-FU and 5000 U heparin daily for 7 days
Trial: 6102865
Drug: Triclofos 70
RxNorm normalized name: Triclofos
DrugBank: Triclofos (DB06753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triclofos 70 mg kg‐1 + atropine 0.03 mg kg‐1
Trial: 6102865
Drug: Diazepam 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.25 mg kg‐1 + atropine 0.03 mg kg‐1